# Nueterra Capital

Nueterra Capital is a Private Equity based in Dallas, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Dallas, United States
- **Region:** North America
- **Address:** 11350 Tomahawk Creek Parkway, Suite 200, Leawood, KS 66211, United States
- **Founded:** 1997
- **Assets under management:** Undisclosed
- **Website:** www.nueterra.com
- **LinkedIn:** https://www.linkedin.com/company/nueterracapital

## Regulatory record

- **Reports private funds:** No

## About

Nueterra Capital is a purpose-driven venture capital firm founded in 1997, focused on the healthcare sector. The firm pursues early-stage investments in digital health companies. It operates from Dallas, Texas.

## Sectors

- Healthcare
- Digital Health

## Offices

- Dallas, TX, United States

## People

- Dan Tasset — Partner
- Jeremy Tasset — Partner
- George Lester — Partner

## Questions

### Who runs investment decisions at Nueterra Capital?

Three partners lead the firm: Dan Tasset, Jeremy Tasset, and George Lester. Dan Tasset founded the predecessor operating company that built and managed over 150 surgery centers. The Tassets and Lester collectively shape investment decisions, drawing on the operational expertise of a 10-person dedicated team and a network of healthcare facility executives.

### How does Nueterra Capital source proprietary deal flow?

The firm leverages its owned and managed healthcare facilities as a live testing environment. Early-stage companies can pilot their technology within these operating sites, which generates real-world validation data and creates a sourcing funnel of founders seeking operational feedback — a circuit that reduces diligence risk and surfaces deals outside the coastal venture hubs.

### How is Nueterra Capital related to NueHealth and Monument Healthcare Properties?

Both entities appear in the Nueterra portfolio as operating companies. NueHealth is the firm's surgery-center platform, and Monument Healthcare Properties held real estate assets that were sold to Grayson Capital — one of Nueterra’s co-investment relationships. These entities form the operational chassis that supplies the firm’s clinical pilot network.

## Related profiles

- [Nuclo Wealth](https://altss.com/profile/nuclo-wealth)
- [NuevaBio](https://altss.com/profile/nuevabio)

---

Last updated: 2026-07-10T08:16:07.000Z

Canonical page: https://altss.com/profile/nueterra-capital-management

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology